Of the 37 million patients in the U.S. with Type 2 diabetes, about half of them suffer from peripheral neuropathy, according to National Institutes of Health estimates. The condition causes numbness, ...

Explore a study by Morehead State University on non-medicinal treatments for diabetes-related nerve pain using transcranial ...

MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, ...

While the immediate goal of bariatric surgery is to help obese patients shed significant weight, new research shows it may also reduce diabetes complications, including nerve damage. Investigators ...

Handheld devices that can detect the telltale signs of peripheral neuropathy in people with diabetes could have another important function—predicting the risk that they will die within the next few ...

After the initial screening history, physical examination, and laboratory assessment, 148 subjects were identified who were potentially eligible and underwent full cardiac evaluation. Twelve subjects ...

Last patient last visit (LPLV) was reached for the 127 adult and elderly patients enrolled into the 12-week placebo-controlled trial with nispomeben (NRD.E1) Topline results are expected in November ...

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...